Literature DB >> 1733224

Natural killer cell activity from pregnant subjects is modulated by RU 486.

K A Hansen1, M S Opsahl, L K Nieman, J R Baker, T A Klein.   

Abstract

Natural killer cells form an integral component of the body's innate immune system. Natural killer cell activity is reduced during pregnancy, especially in the latter half. To investigate the role progesterone may play in immunomodulating natural killer cell activity during pregnancy, we evaluated the effect of RU 486 on natural killer cells isolated from pregnant subjects. Natural killer cell activity was measured with an 18-hour, Chromium 51 release, microcytotoxicity assay with K-562 cells as target cells. We demonstrated that RU 486, in a concentration range from 5 to 40 mumol/L, augmented natural killer activity threefold to fivefold over baseline. This augmentation of activity was suppressed to baseline by the addition of excess progesterone. The addition of hydrocortisone resulted in an insignificant reduction in this augmented activity. This study suggests that progesterone may play a role as an immunomodulating factor in maternal acceptance of the fetal allograft.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733224     DOI: 10.1016/0002-9378(92)91835-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Determination of natural killer cell function by flow cytometry.

Authors:  K L Kane; F A Ashton; J L Schmitz; J D Folds
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

Review 2.  Role of nuclear progesterone receptor isoforms in uterine pathophysiology.

Authors:  Bansari Patel; Sonia Elguero; Suruchi Thakore; Wissam Dahoud; Mohamed Bedaiwy; Sam Mesiano
Journal:  Hum Reprod Update       Date:  2014-11-18       Impact factor: 15.610

Review 3.  The placenta revealed.

Authors:  H J Kliman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

4.  Evidence that exposure to progesterone alone is a sufficient stimulus to cause a precipitous rise in the immunomodulatory protein the progesterone induced blocking factor (PIBF).

Authors:  Rachael A Cohen; Jerome H Check; Michael P Dougherty
Journal:  J Assist Reprod Genet       Date:  2015-12-03       Impact factor: 3.412

5.  Spatiotemporal patterns of macrophage migration inhibitory factor (Mif) expression in the mouse placenta.

Authors:  Miriam R Faria; Mara S Hoshida; Eloisa Av Ferro; Francesca Ietta; Luana Paulesu; Estela Bevilacqua
Journal:  Reprod Biol Endocrinol       Date:  2010-08-04       Impact factor: 5.211

Review 6.  Endocrine factors modulating immune responses in pregnancy.

Authors:  Anne Schumacher; Serban-Dan Costa; Ana Claudia Zenclussen
Journal:  Front Immunol       Date:  2014-05-08       Impact factor: 7.561

7.  The immunological effect of Galectin-9/TIM-3 pathway after low dose Mifepristone treatment in mice at 14.5 day of pregnancy.

Authors:  Adrienn Lajko; Matyas Meggyes; Beata Polgar; Laszlo Szereday
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

Review 8.  The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions.

Authors:  Julia Szekeres-Bartho; Sandra Šućurović; Biserka Mulac-Jeričević
Journal:  Front Immunol       Date:  2018-12-13       Impact factor: 7.561

9.  Mifepristone increases the cytotoxicity of uterine natural killer cells by acting as a glucocorticoid antagonist via ERK activation.

Authors:  Yuezhou Chen; Yan Wang; Yaling Zhuang; Feng Zhou; Lili Huang
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

Review 10.  Sepsis: Precision-Based Medicine for Pregnancy and the Puerperium.

Authors:  Orene Greer; Nishel Mohan Shah; Shiranee Sriskandan; Mark R Johnson
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.